A Tale Of A Visually Impaired Reader 11/11/2010 by Intellectual Property Watch 1 Comment I’d like to introduce myself and put my personal experience in the hands of all concerned parties and people, hoping that this will help to give a better comprehension (explain) about the situation of blind people and to help reach an international treaty that will facilitate access to knowledge for people with visual impairments, writes law professor Mohammed Mohsin Abrahim El Nagaar of Alexandria University.
IFPMA Names President, New Members, R&D Commitments 10/11/2010 by Intellectual Property Watch Leave a Comment The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that David Brennan of AstraZeneca will be its new president, replacing Haruo Naito of pharmaceutical companiy Eisai. They also announced that California-based biotechnology company Amgen has become a member.
Journalism Professor To Lead UK Review Of IP & Growth 10/11/2010 by Intellectual Property Watch Leave a Comment Professor Ian Hargreaves of Cardiff University in Wales will lead an independent review of the intellectual property system’s promotion of growth and innovation launched by the United Kingdom’s Intellectual Property Office on 4 November.
EU Leak On ACTA Shows Path To Completion 09/11/2010 by Intellectual Property Watch Leave a Comment Negotiators of the Anti-Counterfeiting Trade Agreement will meet again after all to “finalise the legal scrub of the ACTA text” and to solve issues “of a technical nature,” according to recently leaked documents from the European Commission. They also show a document agreed by the US and the EU “for a package solution to the […]
Panellists: Copyright Law’s ‘Byzantine Maze’ Stalling New Business Models 09/11/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments While piracy remains an oft-cited problem for the creative content industry, it is the ‘Byzantine maze’ of copyright law that is stalling monetisation of new business models better designed to deliver content in the digital age, panellists at the World Intellectual Property Organization said last week.
November Edition Of IP-Watch Monthly Reporter Now Available 09/11/2010 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment The Intellectual Property Watch Monthly Edition features top news on international IP policymaking, the latest on who is coming and going in the international IP community, news briefs and more. The November edition is now available for subscribers at: http://www.ip-watch.org/user/newsletter.
US Trademark Commissioner Beresford To Retire 09/11/2010 by Intellectual Property Watch Leave a Comment United States Trademark Commissioner Lynne Beresford has announced she will retire on 30 December, according to the US Patent and Trademark Office. Deputy Commissioner for Trademark Operations Deborah Cohn will succeed Beresford and assume her new position as of 31 December.
European Officials Eye Pan-European Passport For Collective Copyright Licencing 08/11/2010 by William New, Intellectual Property Watch Leave a Comment The European Commission is considering a proposal in the coming months to create a pan-European passport for collective music licensing intended to overcome stifling difficulties of 27 national collecting societies, a top official has told Intellectual Property Watch in the context of a meeting on copyright and competition.
WIPO Copyright Committee Tackles Visually Impaired Access, Other Exceptions 08/11/2010 by William New, Intellectual Property Watch 4 Comments The World Intellectual Property Organization Standing Committee on Copyright and Related Rights (SCCR) is meeting this week in an attempt to advance proposals to improve global access to copyrighted works, following a disappointing summer meeting that ended without agreement. This week’s meeting also includes renewed discussions of proposed treaties on broadcasters’ rights and rights over audiovisual performances.
US FDA’s Tough Road Ahead In Creating Pathway For Life-Saving Biologics 07/11/2010 by Liza Porteus Viana, Intellectual Property Watch Leave a Comment The US Food and Drug Administration heard from myriad pharmaceutical companies, patient groups, and other stakeholders last week as the agency considers how to create an abbreviated pathway to bring more biologic drugs to market.